OSI Systems heads into mid-June with short sellers quietly rebuilding positions and options markets turning more defensive — even as the stock posts a solid month-long recovery from its May earnings collapse.
The short interest story is the most pressing tension right now. SI has climbed roughly 11% over the past week to reach 13.8% of free float — a level that qualifies as genuinely elevated. That rebuild comes directly on top of the May 4 earnings release, which sent the stock down nearly 17% in a single session and a further 18% over the following five days. Bears appear to be reloading into the bounce: the stock has recovered 7.4% over the past month and 2.5% this week to $220.70, but short interest has grown alongside that recovery rather than retreating from it. The ORTEX short score has drifted up from 68.2 on June 8 to 71.1 today, ranking in the 2nd percentile on short score — meaning the market views this as one of the more heavily shorted names in the universe relative to its profile. The one moderating signal is in the lending market itself: borrow availability remains comfortable at around 151%, with cost to borrow holding near 0.50% — tight enough to reflect meaningful demand but not so stressed that a squeeze is imminent. The borrow market has tightened noticeably this week though, with availability dropping from around 181% just ten days ago to its current level, the tightest reading in the past month.
Options positioning reinforces the cautious tone. The put/call ratio has climbed to 0.71 — roughly 1.7 standard deviations above its 20-day average of 0.57 — and has risen steadily for three consecutive weeks. For context, the PCR was below 0.47 in late May, immediately after the post-earnings flush. That steady drift upward into more defensive territory, coinciding with the short rebuild, suggests participants are hedging rather than fading the recovery outright. The 52-week PCR range runs from 0.27 to 7.57, so absolute levels are not extreme, but the direction of travel is clear.
The Street is broadly constructive but has become more selective on valuation following the earnings shock. The most recent analyst action — Citigroup cutting its target from $345 to $279 while keeping a Buy rating in mid-May — tells the story cleanly: analysts still see upside from $220.70 to a consensus mean near $300, but the prior targets looked too rich after Q3 results disappointed. JP Morgan holds a Neutral with a $262 target, sitting below the current consensus and below one buy-rated peer clusters anchored around $295–$320. The bull case centres on government contract momentum, strong homeland security spending, and a diversified product mix. Bears point to the lumpiness of that contract pipeline, FX exposure from international operations, and the demonstrated earnings volatility — two consecutive earnings releases have produced double-digit negative reactions. The PE multiple has edged higher to around 20.3x over the past month as the stock recovered, while EV/EBITDA has eased slightly to 13.2x, suggesting the valuation has retraced to a level that leaves less margin for the next miss.
Founder and Executive Chairman Deepak Chopra has been selling in consistent blocks — 20,000 shares each in October 2025, November 2025, February 2026, and May 2026. The May transaction at $281.84 raised $5.6 million and came just before the earnings drop. That cadence looks programmatic rather than opportunistic, but the aggregate pace — roughly $21 million in sales over eight months — is worth noting alongside the short rebuild. The largest institutional holder, BlackRock, added a modest 12,586 shares in the most recent filing period, while Fidelity added a more meaningful 309,395 shares, signalling that passive and active accumulation is still ongoing even as the founder trims.
Next up is the August 21 earnings release — the key question entering that print is whether management can restore confidence in execution after two consecutive large negative reactions, or whether the current short rebuild proves premature.
See the live data behind this article on ORTEX.
Open OSIS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
